四川汇宇制药股份有限公司持股5%以上股东被动减持股份结果公告

Group 1 - The major shareholder, Huang Qianyi, held 27,219,439 shares, representing 6.426% of the total share capital before the passive reduction plan [1] - The passive reduction plan was executed due to a court order, resulting in the forced sale of 1,300,000 shares, which are all unrestricted circulating shares [1] - The completion of the passive reduction was confirmed on February 10, 2026, with a total of 1,300,000 shares sold, accounting for 0.307% of the current total shares [2] Group 2 - The reduction was in compliance with relevant laws and regulations, and the actual reduction matched the previously disclosed plan [3] - There were no violations of the reduction plan or other commitments during the process [3]